Imperial Prostate
@IP_London
Followers
2K
Following
1K
Media
502
Statuses
1K
A collective of expert urologists, medical specialists, and experienced researchers working to change the way the world diagnoses and treats prostate disease
Imperial College, London
Joined January 2019
Thank you for engaging with us this year at the first joint #IPFTSmasterclass - see you in London in 2026! @FocalSociety
2
8
22
The protocol paper for the #IP7PACIFIC RCT is now available online! This trial led by our group and funded by @CR_UK will provide definitive evidence for "fast" biparametric MRI and image-fusion biopsy using a novel trial design 🚨 @NikhilMayor .
1
10
17
RT @UroResearchNBT: Great news! The IP7-PACIFIC Protocol paper has been published 😍 take a look. 👀 @IP_London @….
0
2
0
Great to see our PhD student @NikhilMayor present the #TRANSFORM trial at tonight’s @Uroweb UROwebinar: The role of MRI in prostate cancer screening and diagnosis. Recruitment to start later this year! . @LondonProstate1 @ProstateUK
0
6
26
Congratulations to the #IP2ATLANTA trials team on their presentation being selected for best of #BAUS25 . @LondonProstate1 @Connor_Urol
0
5
16
Finishing up #BAUS25 on the main stage our Clinical Lecturer @Connor_Urol presenting an update on two major UK prostate randomised controlled trial published this year #TRANSLATE #NEUROSAFE
0
6
18
RT @ProstateUKProfs: [4/8] .🦆The TRANSFORM team @NikhilMayor @Fran_Rawlins @AJWLight @philipmcnamee @IP_London @QMULSocialPsych helped supp….
0
4
0
Meanwhile! Back at in London, @Fran_Rawlins gave a brilliant presentation showcasing TRANSFORM at the @ImperialCTU Unit Meeting 2025 #prostatecancer #prostatescreening. @ImperialSandC @ProstateUK @LondonProstate1
0
4
11
Fantastic overview of diagnostic and therapeutic strategies in radiorecurrent prostate cancer by @TaimurShah . Key takeaways - MRI highly sensitive for local disease (even more so with PSMA PET/CT) & focal therapy as effective as RP in the salvage setting #BAUS25
0
5
11
Brilliant prostate cancer abstract session this morning with 4️⃣ presentations from Team IP at #BAUS25. Huge breadth covered including MRI diagnostics, focal therapy, intraoperative margin assessment, and cytoreduction strategies in metastatic disease
1
4
13
Wrapping up the session is @Reddy4Urology with the outcomes of 1379 men undergoing #FocalTherapy with #HIFU 🦾
1
3
9
Next up @cut_tt_chase presents the 5 year oncological outcomes of men with initial negative #ProstateCancer investigations in the #RAPID pathway 🏃
1
4
12
It’s a busy #ProstateCancer session at #BAUS25 - kicking off is @Connor_Urol with the outcomes from the #IP2ATLANTA pilot study 📊
0
3
10
Fantastic to see our FY1 Karen Gao present our data on Rezum for prostates >80mL. Take home - durable results with good patient satisfaction @lyanleung #BAUS25
1
4
14
Powerful opening from @LondonProstate1 to the #BAUS25 plenary session. We have insufficient capacity and data to endorse screening in 2025. New evidence is critically needed first. Watch this space for the £42M #TRANSFORM screening trial - Phase 1 will start later this year
2
7
25
#IP2ATLANTA pilot published @EUplatinum . 🔬 9 in 10 patients have a viable prostate tumour despite ADT+ARTA/Doce. 🚦Early signal in prostate cancer mortality for cytoreductive arms. 📈 Surgery, radiotherapy, ablation + SABR safe -> .n=433 PFS exp.2027!.
0
11
19
A big welcome to @DaUroKing & the @GlanClwydHospital team — first Welsh site to join #IP9ATLAS ! .Excited to work together on this trial for our #ProstateCancer #ActiveSurveillance patients.
0
3
5
RT @AJWLight: It's a real honour to be awarded the Alavi-Mandell Award by @SNM_MI for our work published in @JournalofNucMed on 68Ga-PSMA-1….
0
4
0
RT @VJOncology: 🎥@NikhilMayor of @IP_London outlines the IP7-PACIFIC trial at #EAU25, comparing bpMRI vs mpMRI & biopsy methods in prostate….
0
5
0
1
6
25
RT @RoboticsUrology: “Lower rate of infection and higher rate of detection with TP biopsy” @LondonProstate1 @FocalSociety @SocietySURS http….
0
6
0